- Report
- November 2026
- 178 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 475 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 480 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 212 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 176 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- August 2026
- 115 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 115 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 110 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 110 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2026
- 124 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2026
- 130 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2026
- 115 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- July 2026
- 148 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2026
- 110 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2026
- 131 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- June 2026
- 140 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- April 2026
- 112 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- April 2026
- 113 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 115 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 110 Pages
Global
From €4438EUR$4,750USD£3,708GBP

The Plasmid market is a subset of the biotechnology industry that focuses on the production and sale of plasmids. Plasmids are circular pieces of DNA that can be used to transfer genetic material between cells. They are used in a variety of biotechnological applications, such as gene therapy, gene editing, and vaccine production. Plasmids are also used in research and development, as well as in the production of biopharmaceuticals.
The Plasmid market is highly competitive, with a number of companies offering a variety of products and services. Companies in the market include Thermo Fisher Scientific, Promega Corporation, GenScript, OriGene Technologies, and Addgene. These companies provide a range of products and services, including plasmid DNA, cloning services, and custom plasmid production. They also offer a variety of other services, such as gene synthesis, gene editing, and gene expression analysis. Show Less Read more